Caregiver risk preferences for delaying loss of ambulation in Duchenne muscular dystrophy in the United States
Quantify caregiver risk preferences to inform the "value of hope" for Duchenne muscular dystrophy (DMD) therapies affecting time to loss of ambulation (LoA). Caregivers (medical decision-makers) of patients with DMD were surveyed to evaluate their preferences across 2 therapies with identi...
Saved in:
| Published in: | Current medical research and opinion Vol. 41; no. 8; pp. 1499 - 1509 |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
03.08.2025
|
| Subjects: | |
| ISSN: | 0300-7995, 1473-4877, 1473-4877 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Quantify caregiver risk preferences to inform the "value of hope" for Duchenne muscular dystrophy (DMD) therapies affecting time to loss of ambulation (LoA).
Caregivers (medical decision-makers) of patients with DMD were surveyed to evaluate their preferences across 2 therapies with identical expected (average) time to LoA: 1 with variable (i.e. possibly longer or shorter than average) time to LoA and 1 with fixed (i.e. certain) time to LoA. Time to LoA with the fixed therapy was altered to determine the caregiver's indifference point. Study endpoints were (i) the share of caregivers who preferred the variable (vs fixed) time to LoA therapy; and (ii) the length of fixed time to LoA that would result in caregiver indifference between the variable and fixed therapies, calculated using parameter estimation by sequential testing. The base case examined therapy choice for a hypothetical ambulatory DMD patient aged 9 years; sensitivity analyses explored preferences for younger (aged 5) and older (aged 13) patients.
Among 103 caregivers surveyed, 72 (69.9%) preferred the variable time to LoA therapy for a hypothetical 9-year-old patient with DMD (
< 0.001). Caregivers were willing to give up 11.5 months (
< 0.001) of certain time to LoA for a chance of longer time to LoA. Caregivers' preference for the variable therapy decreased with hypothetical patient age at treatment initiation, from 72.8% (75/103) for age 5 (
< 0.001) to 60.2% (62/103) for age 13 (
= 0.048).
Caregivers of patients with DMD demonstrated risk tolerance (positive value of hope) for therapies that could delay LoA. |
|---|---|
| AbstractList | Quantify caregiver risk preferences to inform the "value of hope" for Duchenne muscular dystrophy (DMD) therapies affecting time to loss of ambulation (LoA).
Caregivers (medical decision-makers) of patients with DMD were surveyed to evaluate their preferences across 2 therapies with identical expected (average) time to LoA: 1 with variable (i.e. possibly longer or shorter than average) time to LoA and 1 with fixed (i.e. certain) time to LoA. Time to LoA with the fixed therapy was altered to determine the caregiver's indifference point. Study endpoints were (i) the share of caregivers who preferred the variable (vs fixed) time to LoA therapy; and (ii) the length of fixed time to LoA that would result in caregiver indifference between the variable and fixed therapies, calculated using parameter estimation by sequential testing. The base case examined therapy choice for a hypothetical ambulatory DMD patient aged 9 years; sensitivity analyses explored preferences for younger (aged 5) and older (aged 13) patients.
Among 103 caregivers surveyed, 72 (69.9%) preferred the variable time to LoA therapy for a hypothetical 9-year-old patient with DMD (
< 0.001). Caregivers were willing to give up 11.5 months (
< 0.001) of certain time to LoA for a chance of longer time to LoA. Caregivers' preference for the variable therapy decreased with hypothetical patient age at treatment initiation, from 72.8% (75/103) for age 5 (
< 0.001) to 60.2% (62/103) for age 13 (
= 0.048).
Caregivers of patients with DMD demonstrated risk tolerance (positive value of hope) for therapies that could delay LoA. Quantify caregiver risk preferences to inform the "value of hope" for Duchenne muscular dystrophy (DMD) therapies affecting time to loss of ambulation (LoA).OBJECTIVESQuantify caregiver risk preferences to inform the "value of hope" for Duchenne muscular dystrophy (DMD) therapies affecting time to loss of ambulation (LoA).Caregivers (medical decision-makers) of patients with DMD were surveyed to evaluate their preferences across 2 therapies with identical expected (average) time to LoA: 1 with variable (i.e., possibly longer or shorter than average) time to LoA and 1 with fixed (i.e., certain) time to LoA. Time to LoA with the fixed therapy was altered to determine the caregiver's indifference point. Study endpoints were (i) the share of caregivers who preferred the variable (vs fixed) time to LoA therapy; and (ii) the length of fixed time to LoA that would result in caregiver indifference between the variable and fixed therapies, calculated using parameter estimation by sequential testing. The base case examined therapy choice for a hypothetical ambulatory DMD patient aged 9 years; sensitivity analyses explored preferences for younger (aged 5) and older (aged 13) patients.METHODSCaregivers (medical decision-makers) of patients with DMD were surveyed to evaluate their preferences across 2 therapies with identical expected (average) time to LoA: 1 with variable (i.e., possibly longer or shorter than average) time to LoA and 1 with fixed (i.e., certain) time to LoA. Time to LoA with the fixed therapy was altered to determine the caregiver's indifference point. Study endpoints were (i) the share of caregivers who preferred the variable (vs fixed) time to LoA therapy; and (ii) the length of fixed time to LoA that would result in caregiver indifference between the variable and fixed therapies, calculated using parameter estimation by sequential testing. The base case examined therapy choice for a hypothetical ambulatory DMD patient aged 9 years; sensitivity analyses explored preferences for younger (aged 5) and older (aged 13) patients.Among 103 caregivers surveyed, 72 (69.9%) preferred the variable time to LoA therapy for a hypothetical 9-year-old patient with DMD (P < 0.001). Caregivers were willing to give up 11.5 months (P < 0.001) of certain time to LoA for a chance of longer time to LoA. Caregivers' preference for the variable therapy decreased with hypothetical patient age at treatment initiation, from 72.8% (75/103) for age 5 (P < 0.001) to 60.2% (62/103) for age 13 (P = 0.048).RESULTSAmong 103 caregivers surveyed, 72 (69.9%) preferred the variable time to LoA therapy for a hypothetical 9-year-old patient with DMD (P < 0.001). Caregivers were willing to give up 11.5 months (P < 0.001) of certain time to LoA for a chance of longer time to LoA. Caregivers' preference for the variable therapy decreased with hypothetical patient age at treatment initiation, from 72.8% (75/103) for age 5 (P < 0.001) to 60.2% (62/103) for age 13 (P = 0.048).Caregivers of patients with DMD demonstrated risk tolerance (positive value of hope) for therapies that could delay LoA.CONCLUSIONSCaregivers of patients with DMD demonstrated risk tolerance (positive value of hope) for therapies that could delay LoA. |
| Author | Zawadzki, Nadine Marin, Moises Audhya, Ivana Sedita, Lauren E. Klimchak, Alexa C. Shafrin, Jason Kulkarni, Natasha |
| Author_xml | – sequence: 1 givenname: Jason surname: Shafrin fullname: Shafrin, Jason – sequence: 2 givenname: Nadine surname: Zawadzki fullname: Zawadzki, Nadine – sequence: 3 givenname: Moises surname: Marin fullname: Marin, Moises – sequence: 4 givenname: Ivana surname: Audhya fullname: Audhya, Ivana – sequence: 5 givenname: Lauren E. surname: Sedita fullname: Sedita, Lauren E. – sequence: 6 givenname: Natasha surname: Kulkarni fullname: Kulkarni, Natasha – sequence: 7 givenname: Alexa C. surname: Klimchak fullname: Klimchak, Alexa C. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40859763$$D View this record in MEDLINE/PubMed |
| BookMark | eNo9kctOwzAQRS1URB_wCSAv2aQ4fiT2EpWnVIkFdB05zqQNJE6wHaT8PYla2MxIM2dmcc8SzWxrAaHrmKxjIskdYYSkSok1JXQsQhDG0zO0iHnKIi7TdIYWExNN0Bwtvf8kJKZSqQs050QKlSZsgexGO9hXP-Cwq_wX7hyU4MAa8LhsHS6g1kNl97huvcdtiXWT97UOVWtxZfFDbw5gLeCm92acjweDD67tDsO0DgfAO1sFKPB70AH8JTovde3h6tRXaPf0-LF5ibZvz6-b-21kqFAhykXOAEhcgKS8JJAmyiSiEFpIQ5lmLE8gLqViiRxnIFTMDNAiN1woysqErdDt8W_n2u8efMiayhuoa22h7X3GKE-YTDknI3pzQvu8gSLrXNVoN2R_GY2AOALGjRmM-fwjMckmF9mfi2xykZ1csF_BunzD |
| Cites_doi | 10.1038/s41572-021-00248-3 10.1016/S1474-4422(18)30024-3 10.1136/jnnp-2014-309405 10.1016/j.jval.2021.04.1284 10.3233/JND-210665 10.1007/s40271-022-00574-y 10.1007/s11136-019-02355-x 10.1515/fhep-2024-0014 10.1016/j.jval.2020.10.003 10.1257/000282802762024700 10.1212/WNL.0000000000012910 10.2307/1914185 10.2307/1913738 10.1016/j.jval.2016.12.005 10.1016/j.jclinepi.2016.03.030 10.18553/jmcp.2020.26.4.400 10.1377/hlthaff.2011.1300 10.1186/s13023-020-01430-8 10.1016/j.jval.2016.11.028 10.1016/j.jhealeco.2024.102857 10.1212/WNL.0000000000002891 10.1016/j.jval.2017.12.007 10.1002/mus.27532 10.2147/PPA.S248295 10.1016/j.jhealeco.2004.10.001 |
| ContentType | Journal Article |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1080/03007995.2025.2550347 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1473-4877 |
| EndPage | 1509 |
| ExternalDocumentID | 40859763 10_1080_03007995_2025_2550347 |
| Genre | Journal Article |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GroupedDBID | --- 00X 03L 0R~ 29F 4.4 5GY 5RE 6J9 6PF AAGDL AALUX AAMIU AAPUL AAQRR AAWTL AAYXX ABBKH ABEIZ ABIVO ABJNI ABLIJ ABLJU ABLKL ABOCM ABUPF ABWVI ABXYU ACENM ACGFO ACGFS ACGOD ACIEZ ADCVX ADRBQ AECIN AENEX AEOZL AFRVT AGDLA AGFJD AGRBW AGYJP AHMBA AIJEM AIRBT AKBVH ALMA_UNASSIGNED_HOLDINGS ALQZU ALYBC AMDAE BABNJ BLEHA BOHLJ CCCUG CITATION CS3 DKSSO DU5 EBS EMOBN F5P H13 HZ~ IPNFZ KRBQP KSSTO KWAYT KYCEM L7B LJTGL M4Z O9- P2P RNANH RVRKI RWL SJN TAE TASJS TBQAZ TDBHL TERGH TFDNU TFL TFW TUROJ UEQFS V1S ~1N .55 .GJ 34G 39C 53G 7X7 88E 88I 8AF 8AO 8FI 8FJ 8R4 8R5 AAJKZ AALIY AAORF AAPXX ABBAB ABUWG ABWCV ABZEW ACKZS ACOPL ACYZI ADBBV ADFOM ADFZZ AEIIZ AFKRA AFLEI AJVHN AZQEC BENPR BPHCQ BRMBE BVXVI CAG CCPQU CGR COF CUY CVF CYYVM CZDIS DRXRE DWQXO DWTOO ECM EIF EJD FYUFA GNUQQ HCIFZ HMCUK J5H JENTW M1P M2P M2Q M44 NPM NUSFT PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO Q2X QQXMO RIG S0X UKHRP X7M ZGI 7X8 |
| ID | FETCH-LOGICAL-c259t-b5b3ee01de824f0e769c65d5a58c23a33b6e1f893685a5e5913ce2dbc45923f63 |
| ISICitedReferencesCount | 0 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001564031500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0300-7995 1473-4877 |
| IngestDate | Thu Sep 04 12:31:03 EDT 2025 Tue Oct 07 09:50:08 EDT 2025 Sat Nov 29 07:25:28 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Keywords | treatment preferences loss of ambulation value of hope value assessment Duchenne muscular dystrophy |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c259t-b5b3ee01de824f0e769c65d5a58c23a33b6e1f893685a5e5913ce2dbc45923f63 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 40859763 |
| PQID | 3246387440 |
| PQPubID | 23479 |
| PageCount | 11 |
| ParticipantIDs | proquest_miscellaneous_3246387440 pubmed_primary_40859763 crossref_primary_10_1080_03007995_2025_2550347 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-08-03 |
| PublicationDateYYYYMMDD | 2025-08-03 |
| PublicationDate_xml | – month: 08 year: 2025 text: 2025-08-03 day: 03 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Current medical research and opinion |
| PublicationTitleAlternate | Curr Med Res Opin |
| PublicationYear | 2025 |
| References | e_1_3_4_4_1 e_1_3_4_3_1 e_1_3_4_2_1 e_1_3_4_9_1 e_1_3_4_8_1 e_1_3_4_7_1 e_1_3_4_20_1 e_1_3_4_6_1 e_1_3_4_5_1 e_1_3_4_23_1 e_1_3_4_24_1 e_1_3_4_21_1 e_1_3_4_22_1 e_1_3_4_27_1 e_1_3_4_28_1 e_1_3_4_25_1 e_1_3_4_26_1 e_1_3_4_29_1 e_1_3_4_31_1 e_1_3_4_30_1 e_1_3_4_12_1 e_1_3_4_35_1 e_1_3_4_13_1 e_1_3_4_34_1 e_1_3_4_10_1 e_1_3_4_33_1 e_1_3_4_11_1 e_1_3_4_32_1 e_1_3_4_16_1 e_1_3_4_17_1 e_1_3_4_14_1 e_1_3_4_15_1 e_1_3_4_18_1 e_1_3_4_19_1 |
| References_xml | – ident: e_1_3_4_9_1 doi: 10.1038/s41572-021-00248-3 – ident: e_1_3_4_13_1 doi: 10.1016/S1474-4422(18)30024-3 – ident: e_1_3_4_32_1 doi: 10.1136/jnnp-2014-309405 – ident: e_1_3_4_33_1 – ident: e_1_3_4_19_1 – ident: e_1_3_4_8_1 doi: 10.1016/j.jval.2021.04.1284 – ident: e_1_3_4_15_1 doi: 10.3233/JND-210665 – ident: e_1_3_4_16_1 – ident: e_1_3_4_35_1 doi: 10.1007/s40271-022-00574-y – ident: e_1_3_4_14_1 doi: 10.1007/s11136-019-02355-x – ident: e_1_3_4_3_1 doi: 10.1515/fhep-2024-0014 – ident: e_1_3_4_21_1 – ident: e_1_3_4_34_1 doi: 10.1016/j.jval.2020.10.003 – ident: e_1_3_4_23_1 doi: 10.1257/000282802762024700 – ident: e_1_3_4_31_1 doi: 10.1212/WNL.0000000000012910 – ident: e_1_3_4_27_1 doi: 10.2307/1914185 – ident: e_1_3_4_25_1 doi: 10.2307/1913738 – ident: e_1_3_4_29_1 doi: 10.1016/j.jval.2016.12.005 – ident: e_1_3_4_6_1 doi: 10.1016/j.jclinepi.2016.03.030 – ident: e_1_3_4_20_1 – ident: e_1_3_4_30_1 doi: 10.18553/jmcp.2020.26.4.400 – ident: e_1_3_4_4_1 doi: 10.1377/hlthaff.2011.1300 – ident: e_1_3_4_11_1 doi: 10.1186/s13023-020-01430-8 – ident: e_1_3_4_5_1 doi: 10.1016/j.jval.2016.11.028 – ident: e_1_3_4_28_1 doi: 10.1016/j.jhealeco.2024.102857 – ident: e_1_3_4_10_1 doi: 10.1212/WNL.0000000000002891 – ident: e_1_3_4_18_1 – ident: e_1_3_4_26_1 – ident: e_1_3_4_17_1 – ident: e_1_3_4_2_1 doi: 10.1016/j.jval.2017.12.007 – ident: e_1_3_4_12_1 doi: 10.1002/mus.27532 – ident: e_1_3_4_22_1 – ident: e_1_3_4_7_1 doi: 10.2147/PPA.S248295 – ident: e_1_3_4_24_1 doi: 10.1016/j.jhealeco.2004.10.001 |
| SSID | ssj0012899 |
| Score | 2.4470298 |
| Snippet | Quantify caregiver risk preferences to inform the "value of hope" for Duchenne muscular dystrophy (DMD) therapies affecting time to loss of ambulation (LoA).... Quantify caregiver risk preferences to inform the "value of hope" for Duchenne muscular dystrophy (DMD) therapies affecting time to loss of ambulation... |
| SourceID | proquest pubmed crossref |
| SourceType | Aggregation Database Index Database |
| StartPage | 1499 |
| SubjectTerms | Adolescent Adult Caregivers - psychology Child Child, Preschool Female Humans Male Middle Aged Muscular Dystrophy, Duchenne - physiopathology Muscular Dystrophy, Duchenne - therapy Time Factors United States Walking |
| Title | Caregiver risk preferences for delaying loss of ambulation in Duchenne muscular dystrophy in the United States |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/40859763 https://www.proquest.com/docview/3246387440 |
| Volume | 41 |
| WOSCitedRecordID | wos001564031500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAWR databaseName: Taylor & Francis customDbUrl: eissn: 1473-4877 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0012899 issn: 0300-7995 databaseCode: TFW dateStart: 19720101 isFulltext: true titleUrlDefault: https://www.tandfonline.com providerName: Taylor & Francis |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9swFBZpN0pfxq5ddika7K042JZlS49lW9keGgbLWNiLsWR5DTR2iOOu3W_Zj93RzXGghe1hLyZIQQadj6NzrO98B6G3sWQSooQiEGHFg6SiIhAVOMOEpCITklMuEtNsIptO2XzOP49Gv30tzNVlVtfs-pqv_qupYQyMrUtn_8Hc_aIwAL_B6PAEs8PzrwyvK4p-aLaFpY2v-kYiRnnhRKtCmtKmSzgeDQtgKVwLL_3t430HVgTfe7LsHEW1vGk36was4SmRO2HqMLj1Wk9Ld_njhIRs7ZwuzBrc-X-5KKq16wRWtNvx78XPovxle2lPNb9_wM11_z9vFu2W-XjalRc3JgL-pPtDD79ixNRw6KxnU9bzJhkJIHvKhq7ZamI5CLKBn4W8jt96ADjGJIHQh3M60a-aQNYUEqvrObD_amkAYBTevJPdVd72U3voXpxRrn3m7Oxbf0elU1VfE6bV2m975yE68KvsBj53ZDMmqpk9RA9cOoJPLYweoZGqH6ODc0e4eILqHk1YowkP0IQBTdijCWs04abCWzThRY09mrBHE-7RpKcBTdiiCVs0PUVfzz7M3n0MXIuOQELevAkEFUSpMCoVi5MqVFnKZUpLWlAmY1IQIlIVVRATpwzGFOURkSouhUwoZBZVSp6h_bqp1XOERSIjlihKRMgTSSrdK1KWRVXSlEmi6BhN_P7lK6vEkkde4Nbtfa73Pnd7P0Zv_C7n4DP1RVhRq6Zrc0gi4NjR0phjdGS3v1_Sm-vFnTMv0eEWwa_Q_mbdqdfovrzaLNr1MdrL5uzYIOUPi7iTCQ |
| linkProvider | Taylor & Francis |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Caregiver+risk+preferences+for+delaying+loss+of+ambulation+in+Duchenne+muscular+dystrophy+in+the+United+States&rft.jtitle=Current+medical+research+and+opinion&rft.au=Shafrin%2C+Jason&rft.au=Zawadzki%2C+Nadine&rft.au=Marin%2C+Moises&rft.au=Audhya%2C+Ivana&rft.date=2025-08-03&rft.eissn=1473-4877&rft.volume=41&rft.issue=8&rft.spage=1499&rft_id=info:doi/10.1080%2F03007995.2025.2550347&rft_id=info%3Apmid%2F40859763&rft.externalDocID=40859763 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-7995&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-7995&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-7995&client=summon |